, Pharmacyclics (NASDAQ: PCYC) made the following promotions: Jesse McGreivy, MD, to Chief Medical Officer; Darrin Beaupre, MD, to Vice President of Clinical Medicine and Early Development; Thorsten Graef, MD, to Vice President of Clinical Science; and Betty Chang, Ph.D., to Vice President of Research/Biology.
Also on July 9, 2013, David Loury, Ph.D., was appointed to the position of Executive Vice President of Toxicology and will no longer hold the position of Chief Scientific Officer; Lori Kunkel, MD, will remain with the Company and will no longer hold the position of Chief Medical Officer; and Joe Buggy, Ph.D., announced his intention to resign as the Company’s Vice President of Research, and will remain with the Company for an indefinite period of time at the Company’s request.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Posted in: News, Management